Cara Therapeutics reported $714.24M in Market Capitalization for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 3.91B 222.46M
Acelrx Pharmaceuticals ACRX:US $ 164.36M 37.85M
Aerie Pharmaceuticals AERI:US $ 750.76M 87.28M
Antares Pharma ATRS:US $ 735.96M 42.2M
Arena Pharmaceuticals ARNA:US $ 4.16B 41.38M
Biodelivery Sciences International BDSI:US $ 352.73M 38.5M
Cara Therapeutics CARA:US $ 714.24M 368.58M
Chugai Pharma 4519:JP 7391.21B 146.08B
Depomed DEPO:US $ 69.41M 48.97M
Endo International Ordinary Shares ENDP:US 1.09B 616.14M
Halozyme Therapeutics HALO:US $ 6.47B 491.5M
Horizon Pharma HZNP:US 21.05B 423.52M
Johnson & Johnson JNJ:US $ 425145.86M 8679.8M
Neurocrine Biosciences NBIX:US $ 9.2B 7.62M
Pacira Pharmaceuticals PCRX:US $ 2.67B 402.93M
Pain Therapeutics PTIE:US $ 3.42B 1.62B
Pfizer PFE:US $ 219205.69M 17108.81M
Redhill Biopharma RDHL:US 321.43M 20.17M
Revance Therapeutics RVNC:US $ 2.13B 132.96M
Supernus Pharmaceuticals SUPN:US $ 1.64B 250.8M
Teva Pharmaceutical Industries TEVA:US 10.99B 1.56B
Vanda Pharmaceuticals VNDA:US $ 1.2B 370.85M